2007Chinese Journal of Drug Application and MonitoringRequires access

Pharmacokinetics study of Pazufloxacin Mesilate in multiple doses to chinese healthy volunteers

Zheng Zhuan-jie

Open publisher page 0 citations

Abstract

Objective:To investigate the pharmacokinetics of pazufloxacin mesilate in multiple doses to Chinese healthy volunteers.Methods:The protocol was designed according to GCP principle.10 volunteers were given multi-dose pazufloxacin mesilate and the plasma concentrations were determined by HPLC method and the pharmacokinetics parameters were calculated by DAS1.0 software.Results:The concentration-time curve fit two compartment model.The main pharmacokinetics parameters C0 of the 1st day and 5th day were (5.73±0.79)mg/L and (5.72±0.82)mg/L respectively,t1/2β were (2.01±0.27)h and (1.85±0.20)h respectively,AUC0-∞ of the 1st day was (13.50±2.47)mg·h·L-1 and AUC0-τ of the 5th day was (14.53±2.71) mg·h·L-1.Conclusion:Effective concentration in vivo could achieved after intravenous infusion of 300mg pazufloxacin mesilate twice a day for 5 days and no accumulation in human body was observed after 5 day administrations.The dosing schedule was recommended.

About this research paper

What this paper is about

Objective:To investigate the pharmacokinetics of pazufloxacin mesilate in multiple doses to Chinese healthy volunteers.Methods:The protocol was designed according to GCP principle.10 volunteers were given multi-dose pazufloxacin mesilate and the plasma concentrations were determined by HPLC method and the pharmacokinetics parameters were calculated by DAS1.0 software.Results:The concentration-time curve fit two compartment model.The main pharmacokinetics parameters C0 of the 1st day and 5th day were (5.73±0.79)mg/L and (5.72±0.82)mg/L respectively,t1/2β were (2.01±0.27)h and (1.85±0.20)h respectively,AUC0-∞ of the 1st day was (13.50±2.47)mg·h·L-1 and AUC0-τ of the 5th day was (14.53±2.71) mg·h·L-1.Conclusion:Effective concentration in vivo could achieved after intravenous infusion of 300mg pazufloxacin mesilate twice a day for 5 days and no accumulation in human body was observed after 5 day administrations.The dosing schedule was recommended.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the pharmacokinetics of pazufloxacin mesilate in multiple doses to Chinese healthy volunteers.Methods:The protocol was designed according to GCP principle.10 volunteers were given multi-dose pazufloxacin mesilate and the plasma concentrations were determined by HPLC method and the pharmacokinetics parameters were calculated by DAS1.0 software.Results:The concentration-time curve fit two compartment model.The main pharmacokinetics parameters C0 of the 1st day and 5th day were (5.73±0.79)mg/L and (5.72±0.82)mg/L respectively,t1/2β were (2.01±0.27)h and (1.85±0.20)h respectively,AUC0-∞ of the 1st day was (13.50±2.47)mg·h·L-1 and AUC0-τ of the 5th day was (14.53±2.71) mg·h·L-1.Conclusion:Effective concentration in vivo could achieved after intravenous infusion of 300mg pazufloxacin mesilate twice a day for 5 days and no accumulation in human body was observed after 5 day administrations.The dosing schedule was recommended.

Key concepts: Pharmacokinetics, Medicine, Dosing, Pharmacology, Plasma concentration, Serum concentration, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics study of Pazufloxacin Mesilate in multiple doses to chinese healthy volunteers — Research Paper | ScholarLens